Alzheimer's disease (AD) is a chronic neurodegenerative disease, which is considered as
one of the most intractable medical problems with heavy social and economic costs. The …

Alzheimer's disease (AD) is a neurodegenerative old age disease that is complex,
multifactorial, unalterable, and progressive in nature. The currently approved therapy …

Dementia is major neurocognitive disorder in which 95% of patients is diagnosed with
Alzheimer's disease, stroke-induced neurodegeneration, or dementia with Lewy Bodies …

Introduction Alzheimer's disease (AD) is increasing in frequency as the global population
ages. Five drugs are approved for treatment of AD, including four cholinesterase inhibitors …

Alzheimer's disease (AD) is a major form of senile dementia, characterized by progressive
memory and neuronal loss combined with cognitive impairment. AD is the most common …

In an ever-increasing aged world, Alzheimer's disease (AD) represents the first cause of
dementia and one of the first chronic diseases in elderly people. With 55 million people …

Alzheimer disease (AD) accounts for 60–70% of dementia cases. Given the seriousness of
the disease and continual increase in patient numbers, developing effective therapies to …

Alzheimer's disease (AD) is the most common chronic neurodegenerative disease
worldwide. It causes cognitive dysfunction, such as aphasia and agnosia, and mental …

Alzheimer's disease (AD) is the most common cause of dementia worldwide. The etiology is
multifactorial, and pathophysiology of the disease is complex. Data indicate an exponential …

Alzheimer's disease (AD) is an irreversible multifaceted neurodegenerative disorder that
gradually degrades neuronal cells. Presently, it is the most common reason for the memory …